Globus Medical (GMED)
(Real Time Quote from BATS)
$74.85 USD
-0.03 (-0.04%)
Updated Nov 4, 2024 03:28 PM ET
2-Buy of 5 2
C Value C Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
GMED 74.85 -0.03(-0.04%)
Will GMED be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for GMED based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GMED
Insulet Stock Gains From Expansion Strategies, Innovation
QGEN Stock Set to Gain From FDA's Clearance of QIAstat-Dx Mini Panel
GMED: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Retain DGX Stock in Your Portfolio Now
CAH Stocks Gains on Q1 Earnings & Sales Beat and Raised '25 EPS View
Boston Scientific Stock Gains From Market Expansion, Innovation
Other News for GMED
Paradice Investment Management LLC Increases Stake in Skillsoft Corp
Globus Medical Inc (GMED) Shares Up 3.6% on Oct 15
Globus Medical (GMED) Receives a Buy from Stifel Nicolaus
Globus Medical price target raised by $1 at BTIG, here's why
The Analyst Verdict: Globus Medical In The Eyes Of 7 Experts